BioHarvest Sciences (XCNQ:BHSC) EV-to-EBIT : -15.68 (As of May. 24, 2024)

View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BioHarvest Sciences's Enterprise Value is C$166.98 Mil. BioHarvest Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-10.65 Mil. Therefore, BioHarvest Sciences's EV-to-EBIT for today is -15.68.

The historical rank and industry rank for BioHarvest Sciences's EV-to-EBIT or its related term are showing as below:

XCNQ:BHSC' s EV-to-EBIT Range Over the Past 10 Years
Min: -37.38 Med: -11.87 Max: -7.47
Current: -15.68

During the past 10 years, the highest EV-to-EBIT of BioHarvest Sciences was -7.47. The lowest was -37.38. And the median was -11.87.

XCNQ:BHSC's EV-to-EBIT is ranked worse than
100% of 1487 companies
in the Consumer Packaged Goods industry
Industry Median: 13.64 vs XCNQ:BHSC: -15.68

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. BioHarvest Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was C$125.71 Mil. BioHarvest Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-10.65 Mil. BioHarvest Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -8.47%.

BioHarvest Sciences EV-to-EBIT Historical Data

The historical data trend for BioHarvest Sciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences EV-to-EBIT Chart

BioHarvest Sciences Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-3.19

-12.00

-17.91

-10.89

-8.84

BioHarvest Sciences Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-11.94	-10.89	-8.97	-15.15	-8.84

Competitive Comparison of BioHarvest Sciences's EV-to-EBIT

For the Packaged Foods subindustry, BioHarvest Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioHarvest Sciences's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's EV-to-EBIT falls into.

BioHarvest Sciences EV-to-EBIT Calculation

BioHarvest Sciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	166.975	/	-10.649
	=	-15.68

BioHarvest Sciences's current Enterprise Value is C$166.98 Mil.
BioHarvest Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-10.65 Mil.

BioHarvest Sciences (XCNQ:BHSC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

BioHarvest Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-10.649	/	125.70692
	=	-8.47 %

BioHarvest Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was C$125.71 Mil.
BioHarvest Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-10.65 Mil.

BioHarvest Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences (XCNQ:BHSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

CNVCF:USA 8MV:Germany

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines